Vitality Watch

Dossier clinicaltrials trial early 27-aug-2026
Small or early-phase human trial or pilot study

A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation

Key claim: A feasibility study is testing a combined anti-aging intervention of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine on systemic inflammation.

Abstract

This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine.

Why this matters

Most consumer-facing ‘anti-aging stacks’ (rapamycin, spermidine, exercise) circulate as biohacker combinations without any trial that actually tests them together. This feasibility study is one of the first to formalise such a stack in a protocol targeting systemic inflammation — meaningful as a trend signal that combination geromedicine is entering structured trials, but with no efficacy readout it does not yet move the evidence needle beyond the individual components.

Source

Link

Briefing card

A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
Stage: trial early · clinicaltrials · 27-aug-2026

If you follow combination anti-aging stacks, this is an early feasibility trial — it will report tolerability of the exercise + spermidine + rapamycin-or-lamivudine regimen, not whether it lowers inflammation or extends healthspan.

A feasibility study is testing a combined anti-aging intervention of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine on systemic inflammation.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07058974

build build 880 · 2bcef25 · 2026-11-18